Recent Advances and Future Prospects of Treatment of Pulmonary Hypertension

Pulmonary hypertension is one of the diffi-cult situations to treat. Complex pathophysiology, association of the multiple comorbidities make clinical scenario challenging. Recently it is being shown that patients who had recovered from coronavirus disease infection, are at risk of developing pulmonary hyper-tension. Studies on animals have been going on to find out newer treatment options. There are recent advancements in the treatment of pulmonary hyper-tension. Role of anticoagulation, recombinant fusion proteins, stem cell therapy are emerging as therapeutic options for affected patients. SGLT2 inhibitors have potential to have beneficial effects on pulmonary hypertension. Apart from the medical managements, advanced interventions are also getting popular. In this review article, the authors have discussed patho-physiology, recent advancement of treatments includ-ing coronavirus disease patients, and future aspect of managing pulmonary hypertension. We have highlighted treatment options for patients with sleep apnea, interstitial lung disease to discuss the challenges and possible options to manage those patients. (Curr Probl Cardiol 2023;48:101236.)